|

Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Qing XIe1

Indications

  • Liver Disease1
  • Intermediate to High Risk of HCC1
  • Chronic Hepatitis b1
  • Liver Cancer1
  • Cancer1

Other1 trial

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.